Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Adrian P M van der Meijden"'
Autor:
Adrian P M van der Meijden
Publikováno v:
BMJ. 317:1366-1369
Bladder cancer is the fifth most common malignancy in Europe and the fourth most common malignancy in the United States. About 75% of patients with bladder cancer are men. The most established risk factors for bladder cancer are cigarette smoking and
Autor:
Adrian P M, van der Meijden
Publikováno v:
Urologic oncology. 7(1)
Adjuvant instillations with chemo- or immunotherapy agents after transurethral resection of Ta, T1 bladder tumors are administered on non-measurable non-visible disease. To know whether adjuvant therapies are efficacious the marker tumor concept has
Publikováno v:
The Journal of urology. 168(5)
We determine if intravesical bacillus Calmette-Guerin (BCG) reduces the risk of progression after transurethral resection to stage T2 disease or higher in patients with superficial (stage Ta, T1 or carcinoma in situ) bladder cancer.A meta-analysis wa
Autor:
ADRIAN P. M. VAN DER MEIJDEN, MAURIZIO BRAUSI, VICTOR ZAMBON, WIM KIRKELS, CHRISTINE DE BALINCOURT, RICHARD SYLVESTER
Publikováno v:
The Journal of urology. 166(2)
After transurethral resection, we compared the efficacy and side effects of weekly intravesical instillations of epirubicin, bacillus Calmette-Guerin (BCG), and BCG plus isoniazid during a 6-week interval followed by 3 weekly maintenance instillation
Autor:
Peter D. J. Vegt, Adrian P. M. van der Meijden, Richard Sylvester, Maurizio Brausi, Wolfgang Holtl, Christine de Balincourt
Publikováno v:
The Journal of Urology. :1249